Resveratrol prevents neurodegeneration in a rat model of diabetes with concurrent AD by activating Sirt1 and its downstream targets to regulate the cholinergic system and control oxidative stress and the inflammatory response. This evidence concerns the gene SIRT1 and Alzheimer disease.